SCHEMBL1128744

SCHEMBL1128744

Brc1ccc(-c2cnn(Cc3ccccc3)c2)cc1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.78
CREBBP Q92793 5/20 0.59
KCNH2 Q12809 2/20 0.56
DYRK1B Q9Y463 1/20 0.54
PIK3CD O00329 1/20 0.52
PIK3CA P42336 1/20 0.52
PIK3CB P42338 1/20 0.52
PI4KA P42356 1/20 0.52
PIK3CG P48736 1/20 0.52
PI4KB Q9UBF8 1/20 0.52
NAMPT P43490 1/20 0.52
FFAR4 Q5NUL3 1/20 0.51
FYN P06241 1/20 0.50
ADORA2A P29274 1/20 0.50
ADORA1 P30542 1/20 0.50
KDR P35968 1/20 0.46
EPHB4 P54760 1/20 0.46
DHODH Q02127 1/20 0.46
CYP3A4 P08684 1/20 0.45
CYP2C9 P11712 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19541847 0.84 L3MBTL1 (0.78) L3MBTL1CREBBPKCNH2DYRK1BPIK3CD
SCHEMBL31489437 0.83 L3MBTL1 (0.71) L3MBTL1CREBBPKCNH2DYRK1BPIK3CD
SCHEMBL25365603 0.83 L3MBTL1 (0.76) L3MBTL1CREBBPKCNH2DYRK1BPIK3CD
SCHEMBL14910272 0.82 L3MBTL1 (0.65) L3MBTL1CREBBPKCNH2DYRK1BPIK3CD
SCHEMBL671242 0.81 TSHR (0.63) L3MBTL1CREBBPDYRK1BADORA2AADORA1
SCHEMBL14466725 0.80 L3MBTL1 (0.71) L3MBTL1CREBBPKCNH2PIK3CDPIK3CA
SCHEMBL12419621 0.80 L3MBTL1 (0.71) L3MBTL1CREBBPKCNH2DYRK1BPIK3CD
SCHEMBL14466721 0.80 L3MBTL1 (0.71) L3MBTL1CREBBPKCNH2PIK3CDPIK3CA
SCHEMBL27885869 0.79 L3MBTL1 (0.76) L3MBTL1KCNH2KDREPHB4CYP3A4
Hydrochloric Acid SCHEMBL14352923 0.79 L3MBTL1 (0.69) L3MBTL1CREBBPKCNH2PIK3CDPIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150368278-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE INFINITY PHARMACEUTICALS, INC. (US) 2015-12-24 US disclosed
US-8957049-B2 Inhibitors of fatty acid amide hydrolase INFINITY PHARMACEUTICALS, INC. (US) 2015-02-17 US disclosed
CN-102046179-B Inhibitors of fatty acid amide hydrolase INFINITY PHARMACEUTICALS INC 2015-01-14 CN disclosed
US-20110172186-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE INFINITY PHARMACEUTICALS, INC. 2011-07-14 US disclosed
CN-102046179-A Inhibitors of fatty acid amide hydrolase INFINITY PHARMACEUTICALS INC 2011-05-04 CN disclosed
EP-2282742-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE Infinity Pharmaceuticals, Inc. (US) 2011-02-16 EP disclosed
WO-2009126691-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE INFINITY PHARMACEUTICALS, INC (US) 2009-10-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110172186-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE FAAH, FAAH2, ASAH1 L3MBTL1 4079/4885CREBBP 3120/4885KCNH2 2716/4885
US-20150368278-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE FAAH, FAAH2, ASAH1 L3MBTL1 4079/4885CREBBP 3120/4885KCNH2 2716/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.